kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
hulio solution
biosimilar collaborations ireland limited - adalimumab - solution - 20mg - adalimumab 20mg - disease-modifying antirheumatic agents
hulio solution
biosimilar collaborations ireland limited - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
hulio solution
biosimilar collaborations ireland limited - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
yuflyma solution
celltrion healthcare co ltd - adalimumab - solution - 40mg - adalimumab 40mg
yuflyma solution
celltrion healthcare co ltd - adalimumab - solution - 40mg - adalimumab 40mg
simlandi solution
jamp pharma corporation - adalimumab - solution - 40mg - adalimumab 40mg
simlandi solution
jamp pharma corporation - adalimumab - solution - 40mg - adalimumab 40mg
simlandi solution
jamp pharma corporation - adalimumab - solution - 80mg - adalimumab 80mg